Thomas Jefferson University researchers developed an AutoML model that distinguishes pituitary macroadenomas from parasellar meningiomas on MRI with over 97% accuracy.
Key Details
- 1AutoML model trained to classify pituitary macroadenomas vs. parasellar meningiomas on preoperative MRI.
- 2Achieved 97.55% overall accuracy, with sensitivities of 97% (macroadenoma) and 98.41% (meningioma), and specificities of 98.96% and 95.53%, respectively.
- 3External validation conducted on 959 additional MRI images.
- 4Model allows different confidence thresholds, aiding both community screening and tertiary centers.
- 5First reported use of AutoML for this specific neuro-oncology imaging task.
- 6The study published in Otolaryngology–Head and Neck Surgery (Dec 2025); presented at AAO-HNSF 2025.
Why It Matters
Accurate, non-invasive differentiation of similar-appearing benign brain tumors using MRI can improve preoperative planning, reduce surgical risks, and ensure patients receive optimal treatment. This demonstrates AutoML's potential to streamline diagnostic AI development and deployment in neuro-radiology.
Source
EurekAlert
Related News
•EurekAlert
New VIS-Fb Nanobody Probes Transform High-Precision Cellular Imaging
Salk and Einstein researchers have developed visible-spectrum antigen-stabilizable fluorescent nanobodies (VIS-Fbs) for sharper, multi-color live-cell imaging with minimal background noise.
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
AI Pathology Model Outperforms PD-L1 in Predicting NSCLC Immunotherapy Response
MD Anderson's Path-IO machine learning platform accurately predicts immunotherapy responses in metastatic non-small cell lung cancer, surpassing current biomarker standards.